Delisting Determination, The Nasdaq Stock Market, LLC, May 2, 2023,
Pear Therapeutics, Inc.
The Nasdaq Stock Market LLC (the Exchange) has determined to remove
from listing the Class A common stock and warrants of Pear
Therapeutics, Inc., effective at the opening of the trading session
on May 12, 2023.
Based on review of information provided by the Company, Nasdaq
Staff determined that the Company no longer qualified for listing
on the Exchange pursuant to Listing Rules 5101, 5110(b), and
IM-5101-1. The Company was notified of the Staff determination
on April 10, 2023. The Company did not appeal the Staff determination
to the Hearings Panel. The Company securities were suspended on
April 19, 2023. The Staff determination to delist the Company
securities became final on April 19, 2023.